BlackRock’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.9K | Sell |
|
|||||
|
2025
Q1 | $36.2K | Hold |
|
|||||
|
2024
Q4 | $99K | Sell |
|
|||||
|
2024
Q3 | $270K | Buy |
|
|||||
|
2024
Q2 | $189K | Sell |
|
|||||
|
2024
Q1 | $458K | Buy |
|
|||||
|
2023
Q4 | $142K | Sell |
|
|||||
|
2023
Q3 | $988K | Buy |
|
|||||
|
2023
Q2 | $1.07M | Buy |
|
|||||
|
2023
Q1 | $964K | Sell |
|
|||||
|
2022
Q4 | $1.42M | Sell |
|
|||||
|
2022
Q3 | $1.52M | Buy |
|
|||||
|
2022
Q2 | $2.32M | Buy |
|
|||||
|
2022
Q1 | $2.74M | Buy |
|
|||||
|
2021
Q4 | $4.39M | Sell |
|
|||||
|
2021
Q3 | $6.52M | Buy |
|
|||||
|
2021
Q2 | $4.18M | Sell |
|
|||||
|
2021
Q1 | $7.93M | Buy |
|
|||||
|
2020
Q4 | $7.84M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.25M | Buy |
|
|||||
|
2019
Q2 | $3.3M | Sell |
|
|||||
|
2019
Q1 | $3.54M | Sell |
|
|||||
|
2018
Q4 | $4.92M | Buy |
|
|||||
|
2018
Q3 | $10.5M | Buy |
|
|||||
|
2018
Q2 | $9.06M | Sell |
|
|||||
|
2018
Q1 | $9.06M | Buy |
|
|||||
|
2017
Q4 | $5.26M | Buy |
|
|||||
|
2017
Q3 | $15K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $7K | Buy |
|
|||||
|
2015
Q3 | $2K | Hold |
|
|||||
|
2015
Q2 | $3K | Buy |
|